Kowal Investment Group’s Halozyme HALO Stock Holding History

Kowal Investment Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-50	Closed	-$2K	–	455
2021 Q3	$2K	Buy	+50	New	+$2.09K	﹤0.01%	803

Other funds holding HALO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Kowal Investment Group's HALO Position: Q4 2021 in Review

Kowal Investment Group sold out of Halozyme (HALO) in Q4 2021, closing a stake of 50 shares — an estimated $2K sold.

Kowal Investment Group first reported a position in HALO in Q3 2021 and held it in 1 quarter. The position peaked at $2K in Q3 2021. 324 funds tracked by Wall St. Rank hold HALO as of Q4 2021.

Kowal Investment Group reported no remaining Halozyme position as of Q4 2021 after selling out during the quarter.
Kowal Investment Group sold 50 Halozyme shares in Q4 2021, an estimated $2K.
Kowal Investment Group first reported a position in Halozyme in Q3 2021 and held it in 1 quarter.
Kowal Investment Group's Halozyme position peaked at $2K in Q3 2021.
324 funds tracked by Wall St. Rank held Halozyme as of Q4 2021.

Based on Kowal Investment Group's 13F filing for Q4 2021, filed 11 Feb 2022.